Rates of severe infection after transrectal ultrasound-guided (TRUS) prostate biopsy that require hospitalization are on the rise, a population-based Swedish study shows. "Over 100,000 biopsies are ...

Figure 1: Needle cores of traditional sextant biopsy (dashed arrows) are placed halfway between the midline and lateral boundary of the prostate We noted several important results from this study: ...

FORT GORDON, Ga. -- A high-tech procedure that makes prostate biopsy more accurate and thorough is being rolled out at Eisenhower Army Medical Center. The procedure merges ultrasound with MRI images ...

Postponing transperineal prostate biopsies in men with suspicious MRI-detected lesions had no effect on biopsy findings, which could have important implications during the COVID-19 pandemic. Delaying ...

A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...

New findings raise questions about the practice of prescribing antibiotics to men prior to prostate biopsy if they have newly elevated PSA levels and a normal digital rectal examination (DRE). The ...

The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B. One randomized trial and a meta-analysis have explored differences in cancer ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...

Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...